The Association of Serum Omentin-1 Levels with Severity of Nonalcoholic Fatty Liver Disease in Correlation with Cardiovascular Risk Factors among Egyptian Women

Relationship between Elevated Liver enzymes and Metabolic syndrome among Egyptian adults

Metabolic syndrome and coronary artery disease in young Egyptians presenting with acute coronary syndrome

Metabolic Syndrome among Tanta Faculty of Medicine Administrative Employees

Serum Fibroblast Growth Factor 19 As A Predictor and Follow Up of Hepatocellular Carcinoma

THE INTERRELATIONSHIP OF METABOLIC SYNDROME AND BEHCET’S DISEASE IN A COHORT OF EGYPTIAN PATIENTS (A cross-sectional study)

The Relationship between Gut Peptides (Polypeptide YY and Ghrelin) Serum Concentration and Metabolic Syndrome Components in Egyptian Male Patients

Serum Nesfatin-1 in Patients with Metabolic Associated Fatty Liver Disease

Serum Fibroblast Growth Factor 21 and Its Relation to Diabetic Kidney (DKD) Disease and Cardiovascular Risk (ASCVD) in Type 2 Diabetic Patients

Fibroblast growth factor-21 is a novel linkage between metabolic parameters, cardiovascular risk, and nephropathy in prediabetes